| Comparison of methods for quantification of global DNA methylation in human cells and tissues S Lisanti, WAW Omar, B Tomaszewski, S De Prins, G Jacobs, G Koppen, ... PloS one 8 (11), e79044, 2013 | 204 | 2013 |
| Mitochondrial Akt regulation of hypoxic tumor reprogramming YC Chae, V Vaira, MC Caino, HY Tang, JH Seo, AV Kossenkov, ... Cancer cell 30 (2), 257-272, 2016 | 198 | 2016 |
| Landscape of the mitochondrial Hsp90 metabolome in tumours YC Chae, A Angelin, S Lisanti, AV Kossenkov, KD Speicher, H Wang, ... Nature communications 4 (1), 2139, 2013 | 173 | 2013 |
| Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s YC Chae, MC Caino, S Lisanti, JC Ghosh, T Dohi, NN Danial, ... Cancer cell 22 (3), 331-344, 2012 | 134 | 2012 |
| Adaptive mitochondrial reprogramming and resistance to PI3K therapy JC Ghosh, MD Siegelin, V Vaira, A Faversani, M Tavecchio, YC Chae, ... Journal of the National Cancer Institute 107 (3), dju502, 2015 | 113 | 2015 |
| Karyopherin-α2 protein interacts with Chk2 and contributes to its nuclear import L Zannini, D Lecis, S Lisanti, R Benetti, G Buscemi, C Schneider, D Delia Journal of Biological Chemistry 278 (43), 42346-42351, 2003 | 88 | 2003 |
| Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks S Lisanti, M Tavecchio, YC Chae, Q Liu, AK Brice, ML Thakur, ... Cell Reports 8 (3), 671-677, 2014 | 68 | 2014 |
| DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues G Buscemi, L Carlessi, L Zannini, S Lisanti, E Fontanella, S Canevari, ... Molecular and cellular biology 26 (21), 7832-7845, 2006 | 63 | 2006 |
| The shelterin protein TRF2 inhibits Chk2 activity at telomeres in the absence of DNA damage G Buscemi, L Zannini, E Fontanella, D Lecis, S Lisanti, D Delia Current Biology 19 (10), 874-879, 2009 | 58 | 2009 |
| Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-directed Cell Motility*[S] M Tavecchio, S Lisanti, A Lam, JC Ghosh, NM Martin, M O'Connell, ... Journal of Biological Chemistry 288 (8), 5553-5561, 2013 | 57 | 2013 |
| REGγ proteasome activator is involved in the maintenance of chromosomal stability L Zannini, D Lecis, G Buscemi, L Carlessi, P Gasparini, E Fontanella, ... Cell Cycle 7 (4), 504-512, 2008 | 56 | 2008 |
| Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis SGJ van Breda, SMH Claessen, K Lo, M van Herwijnen, KJJ Brauers, ... Archives of toxicology 89, 1959-1969, 2015 | 52 | 2015 |
| Deletion of cyclophilin D impairs β-oxidation and promotes glucose metabolism M Tavecchio, S Lisanti, MJ Bennett, LR Languino, DC Altieri Scientific reports 5 (1), 15981, 2015 | 49 | 2015 |
| Inhibition of age-related therapy resistance in melanoma by rosiglitazone-mediated induction of Klotho R Behera, A Kaur, MR Webster, S Kim, A Ndoye, CH Kugel III, GM Alicea, ... Clinical Cancer Research 23 (12), 3181-3190, 2017 | 38 | 2017 |
| Transgenic expression of the mitochondrial chaperone TNFR-associated protein 1 (TRAP1) accelerates prostate cancer development S Lisanti, DS Garlick, KG Bryant, M Tavecchio, GB Mills, Y Lu, ... Journal of Biological Chemistry 291 (48), 25247-25254, 2016 | 38 | 2016 |
| REGγ/PA28γ proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number L Zannini, G Buscemi, E Fontanella, S Lisanti, D Delia Cell Cycle 8 (15), 2399-2407, 2009 | 37 | 2009 |
| Standardization and quality controls for the methylated DNA immunoprecipitation technique S Lisanti, T von Zglinicki, JC Mathers Epigenetics 7 (6), 615-625, 2012 | 26 | 2012 |
| Chk2 phosphorylation of survivin-ΔEx3 contributes to a DNA damage–sensing checkpoint in cancer A Lopergolo, M Tavecchio, S Lisanti, JC Ghosh, T Dohi, A Faversani, ... Cancer research 72 (13), 3251-3259, 2012 | 22 | 2012 |
| Changes in DNA methylation patterns in mammals with senescence, ageing and energy restriction S Lisanti Newcastle University, 2013 | 1 | 2013 |
| Epigenomics: Understanding how nutrition modulates the ageing process S Lisanti, JC Mathers Journal of Nutrigenetics and Nutrigenomics, 2010 | 1 | 2010 |
Michele TavecchioSenior Scientist, NeuroVive Pharmaceutical SADirección de correo verificada de neurovive.com
